![]() |
市場調查報告書
商品編碼
2148748
體外震波碎石設備市場:依設備類型、最終用戶和地區分類。Lithotripsy Devices Market, By Device Type, By End user, By Geography |
||||||
預計到 2026 年,體外碎石市場規模將達到 18.4 億美元,到 2033 年將達到 26.1 億美元。預計從 2026 年到 2033 年,其複合年成長率將達到 5.1%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年: | 2025 | 2026年市場規模: | 18.4億美元 |
| 歷史數據時期: | 2020年至2024年 | 預測期: | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率: | 5.10% | 2033年市場規模預測: | 26.1億美元 |
該市場正經歷穩定成長,主要促進因素包括腎結石和尿道結石發生率的上升、對微創和非侵入性結石治療需求的增加,以及體外震波碎石術(ESWL)和體內碎石系統的技術進步。醫療保健支出的成長、泌尿系統基礎設施的擴建以及技術先進的碎石設備的日益普及,進一步推動了醫院和診所對這些技術的採用。
體外震波碎石術(也稱為體外碎石術)設備能夠透過雷射碎石、超音波碎石、機械碎石和體外震波碎石(ESWL)等技術,將腎結石、輸尿管結石和膀胱結石擊碎並取出。市場正日益轉向更先進的治療平台,這些平台能夠提供更佳的結石擊碎效果、更高的治療效率、更少的結石後移以及更理想的結石清除效果。
為了縮短患者復原時間並改善治療效果,醫療專業人員越來越重視微創結石治療方法。铥光纖雷射(TFL)技術的快速發展,透過實現更快的碎石速度、減少結石後移、使用更細的雷射光纖以及縮短輸尿管鏡檢查時間,進一步革新了腔內碎石術。本研究引用的臨床證據也表明,先進的TFL平台能夠縮短雷射照射時間並提高結石清除率。
由於全球尿道結石負擔日益加重、微創結石治療手段的日益普及以及先進體外震波碎石系統的持續技術發展,市場呈現出強勁的成長動能。老化、代謝紊亂、肥胖、高血壓、飲食習慣改變以及飲水不足等因素導致腎結石和尿道結石的發病率上升,進而導致需要進行積極結石清除手術的患者數量增加。這推動了對體外震波碎石術、雷射碎石術以及其他體內結石破碎系統的需求。
技術進步是影響市場發展的另一個主要因素。從傳統的鈥雷射系統轉向铥光纖雷射平台的轉變,提高了碎石效率,減少了結石後移,並加快了輸尿管鏡手術進程。同時,即時腎內壓監測、具有吸引功能的輸尿管鞘套、先進的可視化技術以及取石技術的整合,正在加速開發更一體化的泌尿外科泌尿系統平台。
人們對非侵入性治療的日益青睞也推動了體外震波碎石術(ESWL)系統的應用。 ESWL 仍然是治療腎結石和輸尿管結石的成熟選擇,因為它無需手術切口,治療時間相對較短,並且在影像導引、衝擊波輸送和結石標靶化不斷改進。預計到 2026 年,ESWL 系統市佔率將達到約 45.5%。
由於醫院集中了泌尿系統,擁有完善的手術室基礎設施、麻醉系統、先進的影像系統以及多種結石治療方案,因此醫院仍然是體外碎石設備的主要終端用戶。醫院也具備處理複雜腎結石和輸尿管結石、高風險患者、術後併發症以及輸尿管鏡和雷射碎石術等手術的良好條件。預計到2026年,醫院市場將占到體外碎石設備市場佔有率的約68.5%。
區域市場發展主要受泌尿系統基礎設施的擴建和先進結石治療技術的廣泛應用所驅動。北美地區憑藉先進的醫療基礎設施、較高的結石治療率以及新一代雷射、抽吸輔助泌尿外科和內視鏡泌尿系統技術的快速普及,預計到2026年將佔據全球市場約41.0%的佔有率。同時,亞太地區預計將成為成長最快的地區,這得益於其龐大的患者群體、不斷擴建的醫院和泌尿系統基礎設施,以及輸尿管軟鏡和雷射碎石術的日益普及。
Lithotripsy Devices Market is estimated to be valued at USD 1.84 Bn in 2026 and is expected to reach USD 2.61 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1.84 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.10% | 2033 Value Projection: | USD 2.61 Bn |
The market is witnessing steady growth, mainly driven by the rising prevalence of kidney and urinary tract stones, increasing preference for minimally invasive and non-invasive stone-management procedures, and technological advancements in extracorporeal shock wave lithotripsy (ESWL) and intracorporeal lithotripsy systems. Increasing healthcare expenditure, expansion of urology infrastructure, and greater availability of technologically advanced lithotripsy devices are further supporting adoption across hospitals and clinics.
Lithotripsy devices enable the fragmentation and removal of kidney, ureteral, and urinary stones through technologies including laser lithotripsy, electrohydraulic lithotripsy, ultrasonic lithotripsy, mechanical lithotripsy, and extracorporeal shock wave lithotripsy (ESWL). The market is increasingly shifting toward advanced treatment platforms that offer improved stone fragmentation, enhanced procedural efficiency, reduced stone retropulsion, and better stone-clearance outcomes.
Healthcare providers are increasingly focusing on minimally invasive stone-management approaches to reduce patient recovery time and improve procedural outcomes. Rapid advancements in thulium fiber laser (TFL) technology are further transforming intracorporeal lithotripsy by enabling faster fragmentation, lower stone retropulsion, use of smaller laser fibers, and shorter ureteroscopic procedures. Clinical evidence cited in the study also demonstrates improvements in laser time and stone-free outcomes associated with advanced TFL platforms.
The market is witnessing significant momentum owing to the growing global burden of urolithiasis, increasing adoption of minimally invasive stone-treatment procedures, and continued technological development in advanced lithotripsy systems. Aging populations, metabolic disorders, obesity, hypertension, dietary changes, and inadequate hydration are contributing to the rising incidence of kidney and urinary stones, thereby increasing the number of patients requiring active stone-removal procedures. This is strengthening demand for extracorporeal shock wave lithotripsy, laser lithotripsy, and other intracorporeal stone-fragmentation systems.
Technological advancement is another major factor influencing market development. The transition from traditional holmium laser systems toward thulium fiber laser platforms is improving fragmentation efficiency, reducing stone retropulsion, and supporting faster ureteroscopic procedures. At the same time, the integration of real-time intrarenal pressure monitoring, suction-enabled ureteral access sheaths, advanced visualization, and stone-evacuation technologies is encouraging the development of more integrated endourology platforms.
The increasing preference for non-invasive treatment is also supporting adoption of extracorporeal shock wave lithotripsy systems. ESWL remains an established treatment option for renal and ureteral stones owing to its avoidance of surgical incisions, relatively short procedure time, and continuing improvements in imaging guidance, shock-wave delivery, and stone targeting. The ESWL system segment is projected to account for approximately 45.5% of the market in 2026.
Hospitals remain the major end users of lithotripsy devices due to the concentration of urologists, operating-room infrastructure, anesthesia capabilities, advanced imaging systems, and availability of multiple stone-treatment modalities. Hospitals are also better equipped to manage complex kidney and ureteral stones, high-risk patients, postoperative complications, and procedures involving ureteroscopy and laser lithotripsy. The hospitals segment is projected to account for approximately 68.5% of the market in 2026.
Regional market development is supported by expanding urology infrastructure and increasing availability of advanced stone-management technologies. North America is projected to account for approximately 41.0% of the global market in 2026, supported by advanced healthcare infrastructure, high utilization of stone-management procedures, and rapid adoption of next-generation laser, suction-assisted, and endourology technologies. Meanwhile, Asia Pacific is expected to be the fastest-growing region owing to its large patient population, expanding hospital and urology infrastructure, and increasing adoption of flexible ureteroscopy and laser lithotripsy procedures.